| Matthew David Auman, MD | |
|
239 W Business 190, Copperas Cove, TX 76522-2912 | |
| (254) 542-9000 | |
| (254) 542-9001 |
| Full Name | Matthew David Auman |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 239 W Business 190, Copperas Cove, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396008124 | NPI | - | NPPES |
| P01512378 | Other | IN | RR MEDICARE |
| 201113260 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01073792A (Indiana) | Secondary |
| 207Q00000X | Family Medicine | S4595 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Adventhealth Central Texas | Killeen, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.
Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart's retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.
Microvesicles are smallest cell elements which are present in all body fluids and are different, depending on whether a person is healthy or sick. This could contribute to detecting numerous diseases, such as, e.g., carcinomas, at an early stage, and to treating them more efficiently. The problem is that the diameter of the relevant microvesicles generally lies below 100 nm, which makes them technically detectable, but their exact size and concentration hardly possible to determine. A new device is now to provide the metrological basis for these promising biomarkers.
The U.S. Centers for Medicare and Medicaid Services (CMS) approved the Fresenius Medical Care Chronic Kidney Disease Data Registry, supported by its Acumen applications. As a participating registry in CMS's 2010 Physician Quality Reporting Initiative (PQRI), the approval of the nephrology-specific Acumen applications enables participating nephrologists to report quality outcomes directly to the PQRI program.
When a loved one dies, memories of that person become particularly valuable in connecting the mourners with the deceased. A new Weill Cornell Medicine online application, called Living Memory Home, offers a virtual and personal memorial space that allows mourners to deposit their memories and feelings about their loss and honor their loved one.
› Verified 4 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.
Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart's retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.
Microvesicles are smallest cell elements which are present in all body fluids and are different, depending on whether a person is healthy or sick. This could contribute to detecting numerous diseases, such as, e.g., carcinomas, at an early stage, and to treating them more efficiently. The problem is that the diameter of the relevant microvesicles generally lies below 100 nm, which makes them technically detectable, but their exact size and concentration hardly possible to determine. A new device is now to provide the metrological basis for these promising biomarkers.
The U.S. Centers for Medicare and Medicaid Services (CMS) approved the Fresenius Medical Care Chronic Kidney Disease Data Registry, supported by its Acumen applications. As a participating registry in CMS's 2010 Physician Quality Reporting Initiative (PQRI), the approval of the nephrology-specific Acumen applications enables participating nephrologists to report quality outcomes directly to the PQRI program.
When a loved one dies, memories of that person become particularly valuable in connecting the mourners with the deceased. A new Weill Cornell Medicine online application, called Living Memory Home, offers a virtual and personal memorial space that allows mourners to deposit their memories and feelings about their loss and honor their loved one.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew David Auman, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-2111 | Matthew David Auman, MD 239 W Business 190, Copperas Cove, TX 76522-2912 Ph: (254) 542-9000 |
News Archive
Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.
Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart's retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.
Microvesicles are smallest cell elements which are present in all body fluids and are different, depending on whether a person is healthy or sick. This could contribute to detecting numerous diseases, such as, e.g., carcinomas, at an early stage, and to treating them more efficiently. The problem is that the diameter of the relevant microvesicles generally lies below 100 nm, which makes them technically detectable, but their exact size and concentration hardly possible to determine. A new device is now to provide the metrological basis for these promising biomarkers.
The U.S. Centers for Medicare and Medicaid Services (CMS) approved the Fresenius Medical Care Chronic Kidney Disease Data Registry, supported by its Acumen applications. As a participating registry in CMS's 2010 Physician Quality Reporting Initiative (PQRI), the approval of the nephrology-specific Acumen applications enables participating nephrologists to report quality outcomes directly to the PQRI program.
When a loved one dies, memories of that person become particularly valuable in connecting the mourners with the deceased. A new Weill Cornell Medicine online application, called Living Memory Home, offers a virtual and personal memorial space that allows mourners to deposit their memories and feelings about their loss and honor their loved one.
› Verified 4 days ago
James Kyle Morsch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 806 E Avenue D Ste H, Copperas Cove, TX 76522 Phone: 254-518-5511 | |
Dr. David Y Go, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 Walker Place Blvd, Copperas Cove, TX 76522 Phone: 254-547-5516 Fax: 254-542-0039 |